Adage Capital Partners Gp, L.L.C. Halozyme Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $14.6 Million - $17.6 Million	400,000 New	400,000 $15.3 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $9.45 Million - $16 Million	287,500 Added 88.06%	614,000 $23.4 Million
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $13.1 Million - $19.4 Million	326,500 New	326,500 $18.6 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $20.6 Million - $34.9 Million	-800,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $5.15 Million - $5.93 Million	-200,000 Reduced 20.0%	800,000 $21 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $4.88 Million - $8.04 Million	300,000 Added 42.86%	1,000,000 $26.8 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $5.91 Million - $9.28 Million	-425,000 Reduced 37.78%	700,000 $12.6 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $5.6 Million - $7.32 Million	375,000 Added 50.0%	1,125,000 $19.9 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $4.56 Million - $5.31 Million	300,000 Added 66.67%	750,000 $11.6 Million
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $4.43 Million - $5.18 Million	300,000 Added 200.0%	450,000 $7.73 Million
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $2.09 Million - $2.64 Million	150,000 New	150,000 $2.42 Million
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $4.27 Million - $5.3 Million	-250,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $2.94 Million - $4.35 Million	250,000	250,000 $4.34 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.